01 October 2022 - 30 September 2027
EdiGenT – New Prime Editing and non-viral delivery strategies for Gene Therapy
The EdiGenT consortium will work to develop a new generation of more efficient gene correction tools based on the CRISPR/Cas9 system, and non-viral delivery strategies for gene therapy.